Ken Thummel
Impact in
- Nephrology top 10%
- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 2
- Co-authors
- Jonathan Himmelfarb (2 shared papers)Karen L. Edwards (3 shared papers)Zejing Wang (1 shared paper)Brian D. Chapron (1 shared paper)Yoshiyuki Yamaura (1 shared paper)Nathan D. Trinklein (1 shared paper)Federico Innocenti (1 shared paper)Thomas J. Laha (1 shared paper)
- Journals
- Alzheimer s & Dementia (1 paper)Public Health Genomics (1 paper)Journal of the American Geriatrics Society (1 paper)Journal of the American Society of Nephrology (1 paper)PLoS Genetics (1 paper)
- Partner nations
- United StatesAustraliaPoland
In The Last Decade
Ken Thummel
10 papers receiving 329 citations
Peers
Comparison fields: 5 of 80
- Nephrology 51
- Pharmacology 52
- Biological Psychiatry 10
- Genetics 81
- Biochemistry 14
Countries citing papers authored by Ken Thummel
This map shows the geographic impact of Ken Thummel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Thummel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Thummel more than expected).
Fields of papers citing papers by Ken Thummel
This network shows the impact of papers produced by Ken Thummel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Thummel. The network helps show where Ken Thummel may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Thummel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 134 | |
| 2 | 2015 | 81 | |
| 3 | 2015 | 47 | |
| 4 | 2008 | 35 | |
| 5 | 2018 | 26 | |
| 6 | 2009 | 5 | |
| 7 | 2016 | 3 | |
| 8 | 1994 | 2 | |
| 9 | 2018 | 2 | |
| 10 | 1991 | 2 |
About Ken Thummel
Ken Thummel is a scholar working on Molecular Biology, Geriatrics and Gerontology, Oncology, Epidemiology and Pharmacology, having authored 10 papers that have together received 337 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Dementia and Cognitive Impairment Research (2 papers), Metabolism and Genetic Disorders (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Genetic Associations and Epidemiology (1 paper). The work is most often cited by research in Nephrology (51 citations), Pharmacology (52 citations), Biological Psychiatry (10 citations), Genetics (81 citations) and Biochemistry (14 citations). Ken Thummel has collaborated with scholars based in United States, Australia and Poland. Frequent co-authors include Jonathan Himmelfarb, Karen L. Edwards, Zejing Wang, Brian D. Chapron, Yoshiyuki Yamaura, Nathan D. Trinklein, Federico Innocenti, Thomas J. Laha, Nancy J. Cox and Wylie Burke. Their work appears in journals such as Alzheimer s & Dementia, Public Health Genomics, Journal of the American Geriatrics Society, Journal of the American Society of Nephrology and PLoS Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.